Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NV/Reno
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Reno, NV

Studies commonly pay $75 to $4,500 per completed study

191 clinical trials are currently recruiting participants within 30 miles of Reno. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

191studies recruiting
4+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Reno right now

Top 25 of 191 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Sierra Eye Associates — Reno, Nevada (2.3 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Geographic Atrophy, Macular Degeneration Phase 2 Interventional 274 participants sought
Sierra Eye Associates — Reno, Nevada (2.3 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06635148)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Gene Upshaw Memorial Tahoe Forest Cancer Center — Truckee, California (23.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8 Phase 3 Interventional 474 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05624996)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05675410)

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Psoriasis, Overweight or Obesity Phase 4 Interventional 200 participants sought
Skin Cancer and Dermatology Institute - Reno — Reno, Nevada (2.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06857942)

Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation

Head and Neck Cancer N/A Interventional 30 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Renown Health
See eligibility & contact on ClinicalTrials.gov (NCT07160296)

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

Acute Respiratory Distress Syndrome (ARDS), ARDS Phase 2 Interventional 200 participants sought
Renown Institute for Heart & Vascular Health — Reno, Nevada (2.3 mi) · Sponsor: PPD Development, LP
See eligibility & contact on ClinicalTrials.gov (NCT06701656)

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL) N/A Observational 550 participants sought
Cancer Care Specialists of Reno — Reno, Nevada (2.3 mi) · Sponsor: Tempus AI
See eligibility & contact on ClinicalTrials.gov (NCT07154823)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
Cancer Care Specialists — Reno, Nevada (2.3 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 150 participants sought
Renown Regional Medical Center /ID# 273535 — Reno, Nevada (2.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06568939)

A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Geographic Atrophy, Macular Degeneration N/A Observational 500 participants sought
Sierra Eye Associates — Reno, Nevada (2.3 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06779773)

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Cognitive Impairment, Mild, Dementia Phase 4 Interventional 20,000 participants sought
Reno VA/Sierra Nevada Health Care — Reno, Nevada (2.3 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT04262206)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung Phase 3 Interventional 830 participants sought
Research Site — Reno, Nevada (2.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06868277)

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase 2 Interventional 240 participants sought
ADARx Clinical Site — Reno, Nevada (2.3 mi) · Sponsor: ADARx Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06990269)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Liver Neoplasms, Primary Liver Cancer N/A Observational 5,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: HistoSonics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06486454)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Non Small Cell Lung Cancer Phase 3 Interventional 780 participants sought
Renown Regional Medical Center-Renown Health Medical Oncology ( Site 0037) — Reno, Nevada (2.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06312137)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Renown Health Medical Oncology — Reno, Nevada (2.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07144280)

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Lumbar Spinal Stenosis N/A Interventional 100 participants sought
Nevada Advanced Pain Specialists — Reno, Nevada (2.3 mi) · Sponsor: Pacific Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT05504499)
Actively enrolling

Studies you may be able to join near Reno

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Reno

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Allied Clinical Research

236 W 6th St Unit 307, Reno, NV 89503
(775) 800-6999

Renown Health Office of Clinical Research

75 Pringle Way Ste 801C, Reno, NV 89502
(775) 982-3646

Center for Molecular Medicine

★ 5.0
0357, 1664 N Virginia St, Reno, NV 89557
(775) 784-6001
"Fantastic institute for Physiology and Cell Biology School of Medicine."
— Rajan Singh, 5★

Advanced Research Institute-Reno

★ 5.0
655 Sierra Rose Dr, Reno, NV 89511
(775) 502-1616
"Lovely staff who are doing important work for patients"
— Ally LaBorde, 4★

Clinical trials in Reno: what's recruiting

The Reno area currently has 191 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Reno, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular2 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Reno, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Reno

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Reno participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Reno pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Reno?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Reno safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Reno, NV?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Reno?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Reno

Other metros within reach

Roseville, CA634 Sacramento, CA633 Elk Grove, CA625 Stockton, CA100 Modesto, CA99 Merced, CA29 Antioch, CA449 Fairfield, CA348

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Reno Bladder Issues Due To Spinal Cord Injury in Reno All conditions

More of NV

Las Vegas446 Henderson446 North Las Vegas446 Enterprise446 Spring Valley446 Sunrise Manor446 Paradise446

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts